NYSE: SONXSonendo Inc Stock
$1.82+0.02 (+1.11%)
Updated Mar 24, 2023
SONX Price
$1.82
Fair Value Price
N/A
Market Cap
$92.06M
52 Week Low
$0.86
52 Week High
$4.41
P/E
-1.43x
P/B
1.12x
P/S
3.05x
PEG
N/A
Dividend Yield
N/A
Revenue
$41.66M
Earnings
-$57.05M
Gross Margin
25.2%
Operating Margin
-129.2%
Profit Margin
-137%
Debt to Equity
0.68
Operating Cash Flow
-$61M
Beta
1.14
Next Earnings
May 9, 2023
Ex-Dividend
N/A
Next Dividend
N/A
SONX Overview
Sonendo Incorporation is a commercial-stage medical technology company. It manufactures devices for root canal therapy and other dental procedures. The company's GentleWave is a tooth decay treatment device for cleaning and disinfecting the microscopic spaces within teeth without the need to remove tooth structure. It also offers SoundSeal, a material used to build and create a sealing platform on the top of the crown; and a Sonendo-branded liquid solution used to debride and disinfect the root canal system. Sonendo was incorporated in 2006 and is headquartered in Laguna Hills, CA.
Zen Score
–
Industry Average (31)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how SONX scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
SONX is unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
SONX is good value based on its book value relative to its share price (1.12x), compared to the US Medical Devices industry average (3.77x)
P/B vs Industry Valuation
SONX is unprofitable, so we... subscribe to Premium to read more.
PEG Value Valuation
There are 30 more SONX due diligence checks available for Premium users.
Be the first to know about important SONX news, forecast changes, insider trades & much more!
SONX News
Valuation
SONX price to earnings (PE)
For valuing profitable companies with steady earnings
Company
-1.43x
Industry
87.96x
Market
21.37x
SONX price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
1.12x
Industry
3.77x
SONX is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation
SONX's financial health
Profit margin
Revenue
$12.2M
Net Income
-$10.9M
Profit Margin
-88.7%
SONX's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
SONX's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$137.3M
Liabilities
$55.3M
Debt to equity
0.68
SONX's short-term assets ($121.11M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
SONX's short-term assets ($121.11M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
SONX's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
-$14.2M
Investing
-$36.4M
Financing
-$167.0k
SONX's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials
SONX vs Medical Device Stocks
Sonendo Stock FAQ
©2023 WallStreetZen
Company
AboutBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.